What the research shows While we're far from definitive answers, there are several biological threads that make researchers want to pull harder
The clinical permutation chosen should therefore reflect not just a woman's symptom profile but her metabolic risk factors, body composition goals, cognitive health priorities, and cardiovascular history
For women dealing with the libido changes and mood shifts that often accompany menopause, addressing these symptoms can indirectly support weight loss adherence and overall quality of life
Sign up for news, trends and insights.
Relevant sources include Novo Nordisk and Eli Lilly announcements ( [5] ) ( [23] ), reputable news reports ( [8] ) ( [9] ), and market/technical studies ( [14] ) ( [22] ), as cited throughout